Vancomycine



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 61.8%
Lung Disorder 11.8%
Diabetic Foot 5.9%
Device Related Infection 2.9%
Meningioma 2.9%
Osteitis 2.9%
Radioisotope Scan 2.9%
Septic Shock 2.9%
Staphylococcal Infection 2.9%
Wrong Drug Administered 2.9%
Red Man Syndrome 16.7%
Thrombocytopenia 16.7%
Epistaxis 8.3%
Hepatocellular Injury 8.3%
Incorrect Dose Administered 8.3%
Influenza Like Illness 8.3%
Pruritus 8.3%
Rash 8.3%
Splenic Vein Thrombosis 8.3%
Wrong Drug Administered 8.3%
Secondary
Product Used For Unknown Indication 46.3%
Drug Use For Unknown Indication 6.6%
Anaesthesia 6.4%
Adult T-cell Lymphoma/leukaemia 3.9%
Lung Disorder 3.7%
Pneumonia 3.4%
Drug Exposure During Pregnancy 2.9%
Acute Myeloid Leukaemia 2.6%
Infection 2.6%
Pain 2.6%
Endocarditis 2.4%
Osteomyelitis 2.4%
Pyrexia 2.3%
Septic Shock 2.1%
Osteitis 1.9%
Antibiotic Therapy 1.8%
Sepsis 1.8%
Diffuse Large B-cell Lymphoma 1.6%
Chemotherapy 1.4%
Pleural Fistula 1.4%
Drug Reaction With Eosinophilia And Systemic Symptoms 13.0%
Renal Failure Acute 11.0%
Thrombocytopenia 10.0%
Pneumonia 7.0%
Toxic Skin Eruption 7.0%
Hepatocellular Injury 6.0%
Skin Exfoliation 5.0%
Skin Test Negative 5.0%
Epistaxis 4.0%
Renal Tubular Necrosis 4.0%
Urticaria 4.0%
Drug Rash With Eosinophilia And Systemic Symptoms 3.0%
Pruritus 3.0%
Rash Maculo-papular 3.0%
Renal Failure 3.0%
Transaminases Increased 3.0%
Vasculitis 3.0%
Acquired Haemophilia 2.0%
Agranulocytosis 2.0%
Condition Aggravated 2.0%
Concomitant
Product Used For Unknown Indication 43.9%
Drug Use For Unknown Indication 10.0%
Haemodynamic Instability 4.0%
Viral Infection 4.0%
Convulsion 3.4%
Grand Mal Convulsion 3.3%
Rhabdomyosarcoma 3.3%
Status Epilepticus 3.3%
Burkitt's Lymphoma 2.9%
Prophylaxis 2.5%
Pyrexia 2.5%
Bone Graft 2.2%
Osteitis 2.2%
Hypertension 2.0%
Prophylaxis Against Graft Versus Host Disease 2.0%
Infection 1.8%
Nosocomial Infection 1.8%
Hyperthermia 1.6%
Neoplasm Malignant 1.6%
Plasma Cell Myeloma 1.6%
Thrombocytopenia 13.0%
Toxic Epidermal Necrolysis 9.3%
Confusional State 7.4%
Cholestasis 5.6%
Pleural Effusion 5.6%
Respiratory Failure 5.6%
Sepsis 5.6%
Septic Shock 5.6%
Toxic Skin Eruption 5.6%
Hypotension 3.7%
Liver Disorder 3.7%
Mucosal Inflammation 3.7%
Pneumonia 3.7%
Rash Maculo-papular 3.7%
Renal Disorder 3.7%
Renal Failure 3.7%
Renal Failure Acute 3.7%
Somnolence 3.7%
Cerebral Haemorrhage 1.9%
Cerebrovascular Accident 1.9%
Interacting
Antibiotic Prophylaxis 100.0%
Renal Failure Acute 100.0%